Rangering i aksjer
#38644
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Aksjekurs
$0.09
Sist synkronisert: 2026-07-28
Handel BNB Plus Corp. (BNBX)
Pris BNBX pris med markedsverdi på B
Markedsverdi av BNB Plus Corp.(BNBX)
Markedsverdi: $876.21K
Per August 2026 har BNB Plus Corp. en markedsverdi på $876.21K. Dette gjør BNB Plus Corp. til det 38644th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for BNB Plus Corp. fra 2006 til 2026
BNBX sammenlignet med topp 5 mest populære stocks
| Pris på BNBX |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.453T
|
+622,371,391.32%
|
|
|
|
|
$4.488T
|
+512,243,027.70%
|
|
|
|
|
$4.161T
|
+474,905,862.78%
|
|
|
|
|
$3.698T
|
+422,075,851.89%
|
|
|
|
|
$2.835T
|
+323,606,608.14%
|
